Generics Industry News Search
 |
|
|
|
|
|
|
August 2010 News Archive |
|
|
| |
|
Sigma Pharmaceuticals has attracted a new bidder for its generics business, valued at about $600 million, with US-based specialty healthcare company Watson Pharmaceuticals considering a grab for the division....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) for Ranitidine Syrup (Ranitidine Oral solution, USP) 15mg (base) /ml....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals-- sumatriptan succinate injection and rocuronium bromide injection....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. announced today that the company received approval from the European Commission to proceed with its acquisition of Ratiopharm...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Medicines Co. won a court ruling that may provide an additional four years of patent protection on its anticoagulant drug Angiomax, which accounts for almost all company revenue...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Federal Court recently found Cobalt's allegation of obviousness justified with respect to Canadian Patent No. 2,111,851 in Novo Nordisk Canada Inc. et al. v. Cobalt Pharmaceuticals Inc. et al. (2010 FC 746; "Novo Nordisk")...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer Inc. apparently has decided not to file suit against a California company looking to market a generic version of...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Generic drug maker Cornerstone Therapeutics has filed for approval of a treatment for cold symptoms, Cornerstone said Thursday...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A second generic version of Sanofi-Aventis's blood-clot drug Lovenox is likely to reach the U.S. market this year, intensifying competition and pushing down prices...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Think Pfizer has had enough of buyouts for awhile, now that it's partially digested the $68 billion Wyeth acquisition? Think again...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett Company, Inc., a manufacturer of generic pharmaceuticals, announced today that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Ondansetron Injection USP, 2 mg/mL, Single-Dose Vials....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. Patent and Trademark Office has acted promptly to comply with Judge Claude Hilton's Order earlier this week that the Office accept The Medicines Company...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's Laboratories Ltd. announced today the launch of Cresp - the first generic darbepoetin alfa in the world, and the only darbepoetin alfa in India. Cresp has been approved in India for the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Drug firm Glenmark Pharmaceuticals today said it has entered into a settlement agreement with American firm Sepracor, which could pave way for the Indian firm to launch generic eszopiclone tablets, used in treating insomnia, in the US market....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharma major Lupin Ltd has filed a legal suit against rival Ranbaxy in the US, alleging patent violation of its cholesterol-lowering drug, Antara....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Endo Pharmaceuticals today announced actions designed to advance the company's leadership and growth in pain management, including an agreement to acquire all outstanding shares of Penwest Pharmaceuticals for $5.00 in cash per share, or an estimated enterprise value of approximately $144 million at the time of deal close....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. announced today that it has completed the acquisition of Ratiopharm, Germany's second largest generics producer...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Betting big on biosimilars or follow-on biologics, Dr Reddy's Laboratories is gearing up to become the largest biosimilar company by tapping the emerging markets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the generic erosion of key agents such as Pfizer's Effexor XR, Eli Lilly/Boehringer Ingelheim's Cymbalta/Xeristar and Forest Laboratories'/Lundbeck's Lexapro/Cipralex/Seroplex, the unipolar depression drug market will decrease in size by nearly 10 percent over the next decade...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Caraco Pharmaceutical Labs and Sun Pharmaceutical Ind. tried to get a rehearing en banc regarding the counterclaim provision of the Hatch-Waxman Act...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer Inc., the world's largest drug company, sued Iceland's Actavis Group hf asking a judge to block sales of a generic version of the cholesterol drug Lipitor until a patent expires in 2017....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Eli Lilly and Company today announced that the U.S. District Court for the District of New Jersey has ruled against the company in its patent litigation for Strattera(R) (atomoxetine). In the case of Eli Lilly and Company v. Actavis Elizabeth LLC, et al, the court ruled that Lilly's '590 patent, or method-of-use patent, for Strattera is invalid....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Cephalon Inc. and Mylan Pharmaceuticals Inc. have agreed to drop two of the three patents originally involved in their infringement suit over the narcolepsy drug Nuvigil...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Following a preliminary injunction ruling, Sandoz Inc. has abandoned its attempt to market a generic version of Mirapex before the expiration of Boehringer's patent...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
On August 5, Alcon Inc.'s request for a permanent injunction against Teva was denied, thus allowing Teva to perform work on a generic version of Vigamox...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Simcere Pharmaceutical Group today announced that its subsidiary company Simcere Dongyuan Pharmaceutical Co., Ltd. has recently received SFDA new drug certification and registration approval to manufacture and market Palonosetron material and injections in China....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Drug maker Glenmark Pharmaceuticals today said it has received US health regulator's nod to sell generic trospium tablets, used for treating urinary problems, in the American market....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. Food and Drug Administration Monday proposed to remove from the market a low-blood pressure drug originally developed by Shire PLC, saying required follow-up clinical studies haven't been conducted...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aspen Pharmacare Holdings Ltd., Africa's largest drugmaker, agreed to buy a unit of Sigma Pharmaceuticals Ltd. for A$900 million ($806 million) in cash to gain assets from a company that's lost about half its value in the past year....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Novartis AG (NVS) has come one step closer in its attempt to win control of eye care company Alcon Inc (ACL) after the Swiss drug giant was able to place five new members on the board of the Switzerland-based firm and won conditional backing from U.S. regulators to proceed with the takeover deal...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Drug company Sun Pharma on Thursday said it has received approval from the US Food and Drug Administration to market generic version of anti-depressant Venlafaxine hydrochloride extended release tablets....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A federal judge has ordered that no generic versions of Eli Lilly & Co.'s (LLY) Strattera drug be launched in the U.S. for two weeks following the entry of a final judgment in a patent dispute over the drug....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Gilead Sciences, Inc. today announced receipt of a Paragraph IV Certification Notice Letter advising that Sigmapharm Laboratories, LLC submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration requesting permission to manufacture and market a generic version of Hepsera(R) (adefovir dipivoxil)....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed by MSP Singapore Co. LLC in connection with VYTORIN(R) (ezetimibe/simvastatin), 10 mg/80 mg....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aurobindo Pharma has announced that the company has received final approvals from the US Food & Drug Administration for 2 ANDAs namely, Ampicillin for Injection USP 125mg, 250mg, 500mg, 1g and 2g per vial and Ampicillin for Injection USP 10g (Pharmacy Bulk Pack) per vial....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV(TM) 200ug" (generic name: dexmedetomidine hydrochloride)....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In a closely watched case that could have major implications for the future of drug competition, Sanofi-Aventis has sued the Food and Drug Administration in bid to halt a generic version of one of its top-selling drugs, a blood thinner made from pig intestines....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In an attempt to launch its own generic controlled-release oxycodone product, Spirit Pharmaceuticals has claimed that Mundipharma's Australian patent for OxyContin is invalid due to a lack of supporting clinical trials. While Mundipharma has recovered from similar challenges in the US, OxyContin revenues will be significantly harmed if Spirit's claim is upheld....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Roche Holding AG won a court ruling in its bid to block generic versions of the osteoporosis drug Boniva from being sold in the U.S...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Celgene Corporation today announced that information was posted on the FDA Web site indicating that an Abbreviated New Drug Application (ANDA) has been received by the Office of Generic Drugs (OGD) containing a "Paragraph IV" patent certification, for REVLIMID (lenalidomide) 25 mg capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Cipla said yesterday that its board of directors has approved the planned purchase of fellow Indian drugmaker Medtitab Specialities for Rs 133.35 crores, or around $28 million....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A U.S. judge on Wednesday refused to block sales of a generic version of Sanofi-Aventis SA's blood thinner marketed by Novartis AG's Sandoz unit and Momenta Inc ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
SOHM, Inc. announced today that it has further broadened its international sales channels in Southeast Asia by signing an exclusive distribution agreement for the marketing and distribution of SOHM's private label generic pharmaceutical products in Sri Lanka....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharmac is to fund a second generic version of a mental health medicine. The decision is expected to save about $24million over five years.
...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
